These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 18806487)

  • 21. [Rules and exceptions in the diagnosis of cutaneous melanoma].
    Urso C
    Pathologica; 2005 Oct; 97(5):323-34. PubMed ID: 16480031
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adhesive tape induced depigmentation. An ultrastructural study and comparison with vitiligo and vitiliginous depigmentation associated with melanoma (author's transl)].
    Frenk E; Kocsis M
    Dermatologica; 1974; 148(5):276-84. PubMed ID: 4420330
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypomelanosis of the skin and malignant melanoma (author's transl)].
    Ortonne JP; Gauthier Y; Guillet G; Gauthier O
    Ann Dermatol Venereol; 1978 Dec; 105(12):1043-52. PubMed ID: 753117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
    PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verrucous malignant melanoma.
    Steiner A; Konrad K; Pehamberger H; Wolff K
    Arch Dermatol; 1988 Oct; 124(10):1534-7. PubMed ID: 2971338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bane of atypical capsular melanocytes.
    Feeney K; Kairys J
    Semin Oncol; 2005 Dec; 32(6):596-7. PubMed ID: 16338426
    [No Abstract]   [Full Text] [Related]  

  • 27. Spontaneous regression of metastases from melanoma: review of the literature.
    Kalialis LV; Drzewiecki KT; Klyver H
    Melanoma Res; 2009 Oct; 19(5):275-82. PubMed ID: 19633580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
    Garbelli S; Mantovani S; Palermo B; Giachino C
    Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical presentation of pedunculated, amelanotic melanoma: plantar aspect.
    Southerland CC; Wasserman LM; Ostapchuk AP
    J Foot Surg; 1991; 30(1):72-9. PubMed ID: 2002191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraepidermal epidermotropic metastatic melanoma: a clinical and histopathological mimicker of melanoma in situ occurring in multiplicity.
    Lestre S; João A; Ponte P; Peixoto A; Vieira J; Teixeira MR; Fidalgo A
    J Cutan Pathol; 2011 Jun; 38(6):514-20. PubMed ID: 21352266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain.
    Hendi A; Brodland DG; Zitelli JA
    Arch Dermatol; 2006 Jul; 142(7):871-6. PubMed ID: 16847203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermotropic malignant melanoma: the distinction between metastatic and new primary lesions in the skin.
    Jackson R
    Can J Surg; 1984 Nov; 27(6):533-5. PubMed ID: 6388769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perilesional vitiligo in melanoma.
    Pantoja E; Wendth AJ; Beecher TS
    Cutis; 1977 Jan; 19(1):51-3. PubMed ID: 837717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vitiliginous depigmentation in patients suffering from malignant melanoma].
    Frenk E
    Dermatologica; 1969; 139(1):84-91. PubMed ID: 5810156
    [No Abstract]   [Full Text] [Related]  

  • 35. Perilesional leucoderma in metastatic melanoma. The use of the Wood's light for early detection of this rare reaction.
    Goldman L; Wilson RG; Glasgow R; Richfield R
    Acta Derm Venereol; 1967; 47(5):369-72. PubMed ID: 4168797
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypopigmented malignant melanoma simulating vitiligo.
    Kossard S; Commens C
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):840-2. PubMed ID: 2347968
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
    Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
    Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
    [No Abstract]   [Full Text] [Related]  

  • 38. Follicular malignant melanoma: a case report of a metastatic variant and review of the literature.
    Hu SW; Tahan SR; Kim CC
    J Am Acad Dermatol; 2011 May; 64(5):1007-10. PubMed ID: 21496718
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimelanoma immunity in vitiligo and melanoma patients.
    Juranic ZD; Stanojevic-Bakic N; Zizak Z; Babovic N; Radovic-Kovacevic V; Stanojkovic T; Dzodic R
    Neoplasma; 2003; 50(4):305-9. PubMed ID: 12937846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraepidermal animal-type melanoma.
    Punjabi S; Wright C; Teixeira F; Stamp G; Chu A
    Int J Dermatol; 2006 Aug; 45(8):957-9. PubMed ID: 16911384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.